全部股東
股東類型
- 機構投資者44.74%
- 公眾及其他35.79%
- 個人與內幕人士14.83%
- 上市公司3.22%
- 私人企業1.42%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
JPMorgan Chase & Co. | 8.96% | 3,043.73 萬 | 1.34% | +461.40 萬 | 21/07/2026 |
JPMorgan Chase & Co. | 8.96% | 3,043.73 萬 | 1.23% | +418.16 萬 | 21/07/2026 |
State Street Investment Management | 7.04% | 2,393.03 萬 | 2.79% | -941.80 萬 | |
State Street Investment Management | 7.04% | 2,393.03 萬 | 1.65% | -561.54 萬 | |
Andreas KlugeChief Medical Advisor | 6.67% | 2,267.50 萬 | 0.02% | +0 | |
Andreas KlugeChief Medical Advisor | 6.67% | 2,267.50 萬 | 0.01% | +0 | |
Christian BehrenbruchCo-Founder, MD, Group CEO & Executive Director | 6.41% | 2,179.69 萬 | <0.01% | +6.79 萬 | 26/05/2026 |
Christian BehrenbruchCo-Founder, MD, Group CEO & Executive Director | 6.41% | 2,179.69 萬 | <0.01% | +6.79 萬 | 26/05/2026 |
Challenger Limited | 4.98% | 1,690.73 萬 | 0.07% | -19.52 萬 | |
Challenger Limited | 4.98% | 1,690.73 萬 | 0.07% | -19.52 萬 | |
Citigroup Inc. | 3.35% | 1,139.14 萬 | 0.01% | +6.04 萬 | 30/06/2026 |
Citigroup Inc. | 3.35% | 1,139.14 萬 | 0.01% | +6.04 萬 | 30/06/2026 |
Grand Pharmaceutical Group Limited | 3.22% | 1,094.72 萬 | <0.01% | +0 | |
Grand Pharmaceutical Group Limited | 3.22% | 1,094.72 萬 | <0.01% | +0 | |
Vanguard Capital Management, LLC | 3.12% | 1,059.30 萬 | <0.01% | +2.07 萬 | 31/07/2026 |
Vanguard Capital Management, LLC | 3.11% | 1,057.24 萬 | 0.34% | +118.00 萬 | 30/06/2026 |
Australian Super Pty Ltd | 2.26% | 768.79 萬 | <0.01% | +0 | 31/12/2025 |
Australian Super Pty Ltd | 2.26% | 768.79 萬 | <0.01% | +0 | 31/12/2025 |
Norges Bank Investment Management | 1.89% | 642.91 萬 | <0.01% | +0 | 31/12/2025 |
Norges Bank Investment Management | 1.89% | 642.91 萬 | <0.01% | +0 | 31/12/2025 |